Surface-modified hydroxyapatite linked byL-lactic acid oligomer in the absence of catalyst

State Key Laboratory of Polymer Physics and Chemistry, Chinese Academy of Sciences, Peping, Beijing, China
Journal of Polymer Science Part A Polymer Chemistry (Impact Factor: 3.11). 11/2005; 43(21):5177-5185. DOI: 10.1002/pola.21006


A new surface modification method of hydroxyapatite nanoparticles (n-HA) by surface grafting reaction of L-lactic acid oligomer with carboxyl terminal (LAc oligomer) in the absence of any catalyst was developed. The LAc oligomer with a certain molecular weight was directly synthesized by condensation of L-lactic acid. Surface-modified HA nanoparticles (p-HA) were attested by Fourier transformation infrared spectroscopy, 31P MAS-NMR, and thermal gravimetric analysis (TGA). The results showed that LAc oligomer could be grafted onto the n-HA surface by forming a Ca carboxylate bond. The grafting amount of LAc oligomer was about 13.3 wt %. The p-HA/PLLA composites showed good mechanical properties and uniform microstructure. The tensile strength and modulus of the p-HA/PLLA composite containing 15 wt % of p-HA were 68.7 MPa and 2.1 GPa, respectively, while those of the n-HA/PLLA composites were 43 MPa and 1.6 GPa, respectively. The p-HA/PLLA composites had better thermal stability than n-HA/PLLA composites and neat PLLA had, as determined by isothermal TGA. The hydrolytic degradation behavior of the composites in phosphate buffered saline (PBS, pH 7.4) was investigated. The p-HA/PLLA composites lost their mechanical properties more slowly than did n-HA/PLLA composites in PBS because of their reinforced adhesion between the HA filler and PLLA matrix. © 2005 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 43: 5177–5185, 2005

7 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Novel bioactive glass (BG) nanoparticles/poly(L-lactide) (PLLA) composites were prepared as promising bone-repairing materials. The BG nanoparticles (Si:P:Ca=29:13:58 weight ratio) of about 40nm diameter were prepared via the sol-gel method. In order to improve the phase compatibility between the polymer and the inorganic phase, PLLA (M(n)=9700Da) was linked to the surface of the BG particles by diisocyanate. The grafting ratio of PLLA was in the vicinity of 20 wt.%. The grafting modification could improve the tensile strength, tensile modulus and impact energy of the composites by increasing the phase compatibility. When the filler loading reached around 4 wt.%, the tensile strength of the composite increased from 56.7 to 69.2MPa for the pure PLLA, and the impact strength energy increased from 15.8 to 18.0 kJ m(-2). The morphology of the tensile fracture surface of the composite showed surface-grafted bioactive glass particles (g-BG) to be dispersed homogeneously in the PLLA matrix. An in vitro bioactivity test showed that, compared to pure PLLA scaffold, the BG/PLLA nanocomposite demonstrated a greater capability to induce the formation of an apatite layer on the scaffold surface. The results of marrow stromal cell culture revealed that the composites containing either BG or g-BG particles have much better biocompatibility compared to pure PLLA material.
    Acta Biomaterialia 08/2008; 4(4):1005-15. DOI:10.1016/j.actbio.2008.02.013 · 6.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Biphasic calcium phosphate (BCP)/poly l-lactide (PLLA) biocomposite is proven to be a promising bone graft material or scaffold for bone tissue engineering. To improve the interfacial compatibility of BCP bioceramic with biopolymer-PLLA, BCP powders were surface-modified in different condition to graft polymer groups onto the surface of the BCP powders. l-lactide and l-lactic acid (LA) oligomer were used to modify the BCP surface with stannous octanoate (Sn(Oct)2) and stannous chloride (SnCl2) as catalyst, respectively. Results show that the surface modification effect is obvious and the amount of grafted organic group is above 6.5wt.%. Sn(Oct)2 and SnCl2 are the optimal catalysts for the surface grafting reaction of l-lactide and l-LA oligomer, respectively. The surface grafting slightly increase the particle size of BCP powders and reduce the tendency for their agglomeration.
    Applied Surface Science 11/2008; 255(2):477-479. DOI:10.1016/j.apsusc.2008.06.182 · 2.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nanohydroxyapatite (op-HA) surface-modified with l-lactic acid oligomer (LAc oligomer) was prepared by LAc oligomer grafted onto the hydroxyapatite (HA) surface. The nanocomposite of op-HA/PLGA with different op-HA contents of 5, 10, 20 and 40wt.% in the composite was fabricated into three-dimensional scaffolds by the melt-molding and particulate leaching methods. PLGA and the nanocomposite of HA/PLGA with 10wt.% of ungrafted hydroxyapatite were used as the controls. The scaffolds were highly porous with evenly distributed and interconnected pore structures, and the porosity wasaround 90%. Besides the macropores of 100-300microm created by the leaching of NaCl particles, the micropores (1-50microm) in the pore walls increased with increasing content of op-HA in the composites of op-HA/PLGA. The op-HA particles could disperse more uniformly than those of pure HA in PLGA matrix. The 20wt.% op-HA/PLGA sample exhibited the maximum mechanical strength, including bending strength (4.14MPa) and compressive strength (2.31MPa). The cell viability and the areas of the attached osteoblasts on the films of 10wt.% op-HA/PLGA and 20wt.% op-HA/PLGA were evidently higher than those on the other composites. For the animal test, there was rapid healing in the defects treated with 10 and 20wt.% op-HA/PLGA, where bridging by a large bony callus was observed at 24weeks post-surgery. There was non-union of radius defects implanted with PLGA and in the untreated group. This was verified by the Masson's trichrome staining photomicrographs of histological analysis. All the data extrapolated that the composite with 10 and 20wt.% op-HA exhibited better comprehensive properties and were the optimal composites for bone repairing.
    Acta biomaterialia 04/2009; 5(7):2680-92. DOI:10.1016/j.actbio.2009.03.024 · 6.03 Impact Factor
Show more